T Cell PTLD Successfully Treated With Single-Agent Brentuximab Vedotin First-Line Therapy. Issue 3 (March 2016) - Choi, Mira; Fink, Susanne; Prasad, Vikas; Anagnostopoulos, Ioannis; Reinke, Petra; Schmitt, Clemens A.